We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Gottlieb Highlights Agency’s Commitment to Expanded Access to Trials
Gottlieb Highlights Agency’s Commitment to Expanded Access to Trials
Commissioner Scott Gottlieb unveiled a redesigned FDA website on expanded access to clinical trials on Thursday and said the agency is “deeply committed” to helping critically ill patients with no other treatment options to join trials.